NCT06788197 A Study of SHR-A1811 and Fulvestrant, With or Without HS-10352, in Locally Advanced or Metastatic Breast Cancer Patients Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT06787807 Proteomic Analysis of Patients Undergoing Bariatric Surgery Status NOT_YET_RECRUITING Phase NA
NCT06787339 Capecitabine in Low Risk Triple Negative Breast Cancer Status NOT_YET_RECRUITING Phase PHASE2
NCT06786598 The Effect of Body Mass Index and Total Cholesterol Levels on Histopathological Grading in Breast Cancer Patients Status COMPLETED Phase NA
NCT06786585 Extended Clinical Follow up and Biospecimen Collection for Patients Enrolled in TAILORx and RxPONDER: A Companion Protocol Status NOT_YET_RECRUITING Phase N/A
NCT06781996 A Study to Determine the Efficacy of a Digital Self-management Support Tool to Improve the Quality of Life During Adjuvant HOrmonal Therapy for Patients With Early Breast Cancer Status RECRUITING Phase PHASE3
NCT06780748 Photo-medicine-Guided Dual Approach for Reoperation of Sentinel Lymph Nodes in Locally Recurrent Breast Cancer Patients Status RECRUITING Phase PHASE2
NCT06780735 Surgical Outcome of BCS Using ICG-F in Breast Cancer Patients After Preoperative Chemotherapy Status RECRUITING Phase NA
NCT06780176 A Study of Breast Cancer Risk Factors and Outcomes of People in Florida Status RECRUITING Phase N/A
NCT06778863 A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation Status RECRUITING Phase PHASE1
NCT06777537 Neoadjuvant Chemotherapy with or Without Talniflumate for the Treatment of Breast Cancer Status NOT_YET_RECRUITING Phase PHASE4
NCT06775236 Clinical Trial of SYS6010±SYH2051 Versus Chemotherapy in Advanced Breast Cancer and Other Solid Tumors Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT06773533 Registry of Adjuvant Hormone-blockade Breast Cancer Patients Evaluated for Bone Mineral Metabolism Status RECRUITING Phase N/A
NCT06772935 Electroacupuncture Treatment of Peripheral Neuropathy After Taxane Chemotherapy for Breast Cancer Status RECRUITING Phase NA
NCT06770296 The Dosing Regimen of Pyrotinib in HER2-positive Advanced First-line Breast Cancer: a Phase I Clinical Study Status RECRUITING Phase PHASE1
NCT06769919 A Randomized Controlled Study on the Efficacy and Safety of Neoadjuvant Radiotherapy Combined with Systemic Therapy for Early-stage Breast Cancer Status NOT_YET_RECRUITING Phase PHASE2/PHASE3
NCT06768931 Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer Status RECRUITING Phase PHASE2